Hepatobiliary Neoplasia 1: Clinical Behaviors

Nov 08 2026
Convention Center: Bluebird Ballroom 2ABC
11:00 AM - 12:30 PM
Captured/recorded session Recorded
CE Credits CE Credits

World Class Speakers

Amit G Singal

Abstract Presenter
Amit G Singal, MD, MS, FAASLD

Anjana Pillai

Moderator
Anjana Pillai, MD, FAASLD

John P Rice

Moderator
John P Rice, MD

Description

This session presents advances in HCC detection and prognostication, including deep learning imaging models, circulating biomarkers, and structured surveillance program outcomes.

Presentations

11:00 AM - 11:15 AM
Convention Center - Bluebird Ballroom 2ABC
Recorded session

Changing Clinical Patterns and Outcomes of Hepatocellular Carcinoma Across Treatment Eras: A Multicenter Cohort Study

Amit G Singal, MD, MS, FAASLD | Abstract Presenter
11:15 AM - 11:30 AM
Convention Center - Bluebird Ballroom 2ABC
Recorded session

Effectiveness of a Structured Surveillance Program for Early Detection of Hepatocellular Carcinoma in Contemporary Patients with Advanced Chronic Liver Disease

Amit G Singal, MD, MS, FAASLD | Abstract Presenter
11:30 AM - 11:45 AM
Convention Center - Bluebird Ballroom 2ABC
Recorded session

A Plasma DNA Methylation Biomarker Panel from the Whole-Body Atlas™ Enables Accurate Detection of Early-Stage HCC

Amit G Singal, MD, MS, FAASLD | Abstract Presenter

Objectives

  • Review the temporal changes regarding hepatocellular carcinoma (HCC) at US academic medical centers
  • Evaluate surveillance for HCC in a greater risk population
  • Consider some emerging early detection modalities in HCC

Copyright © 2026 American Association for the Study of Liver Diseases

AASLD 2026